Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Melanoma Medicine & Life Sciences
Interleukin-2 Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Safety Medicine & Life Sciences
Interleukin-1alpha Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2017

A first-in-human phase I, multicenter, open-label, dose-escalation study of the oral RAF/VEGFR-2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status

Izar, B., Sharfman, W., Hodi, F. S., Lawrence, D., Flaherty, K. T., Amaravadi, R., Kim, K. B., Puzanov, I., Sosman, J., Dummer, R., Goldinger, S. M., Lam, L., Kakar, S., Tang, Z., Krieter, O., Mcdermott, D. F. & Atkins, M. B. 2017 (Accepted/In press) In : Cancer Medicine.

Research output: Research - peer-reviewArticle

Vascular Endothelial Growth Factor Receptor-2
Melanoma
Mutation
RAF265
Neoplasms

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

Lipson, E. J., Lilo, M. T., Ogurtsova, A., Esandrio, J., Xu, H., Brothers, P., Schollenberger, M., Sharfman, W. H. & Taube, J. M. Mar 21 2017 In : Journal for ImmunoTherapy of Cancer. 5, 1, 23

Research output: Research - peer-reviewArticle

Basal Cell Carcinoma
Ligands
Neoplasms
Therapeutics
Tumor-Infiltrating Lymphocytes

BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis

Maxwell, R., Garzon-Muvdi, T., Lipson, E. J., Sharfman, W. H., Bettegowda, C., Redmond, K. J., Kleinberg, L. R., Ye, X. & Lim, M. Jun 15 2017 In : International Journal of Cancer. 140, 12, p. 2716-2727 12 p.

Research output: Research - peer-reviewArticle

Melanoma
Neoplasm Metastasis
Recurrence
Brain
Mutation
Enterocolitis
Steroids
ipilimumab
Diarrhea
Infliximab

Efficacy and safety of nilotinib in patients with kit-mutated metastatic or inoperable melanoma: Final results from the global, single-arm, phase ii team trial

Guo, J. , Carvajal, R. D. , Dummer, R. , Hauschild, A. , Daud, A. , Bastian, B. C. , Markovic, S. N. , Queirolo, P. , Arance, A. , Berking, C. , Camargo, V. , Herchenhorn, D. , Petrella, T. M. , Schadendorf, D. , Sharfman, W. , Testori, A. , Novick, S. , Hertle, S. , Nourry, C. , Chen, Q. & 1 others Hodi, F. S. Jun 1 2017 In : Annals of Oncology. 28, 6, p. 1380-1387 8 p., mdx079

Research output: Research - peer-reviewArticle

Melanoma
Safety
4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide
Dacarbazine
Mutation